Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT07140328 · RECRUITING
Trial details
- NCT number
- NCT07140328
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-24
- Primary completion
- 2025-07-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.